GMDI recognizes that the infant and metabolic formula supply issues is important to members and to the families we work with. Below are links to relevant information. We are working to keep this as up-to-date as possible.
January 25, 2023 - PKU Start - Update from Vitaflo
November 14, 2022 - PKU Start - Update from Vitaflo
October 3, 2022 - Update from Vitaflo
September 30, 2022 - Update from Abbott
September 12, 2022 - Update from Abbott
July 6, 2022
July 6, 2022 – FDA Update: FDA Developing New Framework for Continued, Expanded Access to Infant Formula Options for US Parents and Caregivers
July 6, 2022- FDA Infant formula Update/ Vitaflo
July 2, 2022
FDA Update: Information Regarding Medically Necessary Specialty Infant Formulas: Notice to Health Care Providers FDA Update: Information Regarding Medically Necessary Specialty Infant Formulas: Notice to Health Care Providers
June 23, 2022
Coram Access Discontinuation for Selected Metabolic Formulas
June 16, 2022
Update from Abbott
---
May 26, 2022
Updated Press Release from FDA
May 24, 2022
Today, the U.S. Food and Drug Administration provided an update on steps it has taken that will lead to millions of cans of additional infant and specialty formula being available to U.S. consumers. Links to the press release and webpage are below.
Press release:
FDA Flexibilities to Yield Millions of Cans of Additional Infant Formula in Coming Months to Increase Supply Available to U.S. Consumers | FDA [fda.gov]
Webpage:
Enforcement Discretion to Manufacturers to Increase Infant Formula Supplies | FDA [fda.gov]
--
Time Sensitive: May 17th FDA Stakeholders Call
May 16, 2022 - FDA provides new update
https://metabolicformula.org/ - Statement on metabolic formula supply issues – A coalition of family support groups and other foundations has posted a statement and relevant links to their website, including statements from manufacturers of metabolic formulas about product supply.
May 13, 2022 - Statement from Abbott
May 11, 2022 - FDA Takes Important Steps to Improve Supply of Infant and Specialty Formula Products
FDA Investigation of Cronobacter Infections: Powdered Infant Formula (February 2022)
If you have information to add, please contact us at info@gmdi.org
For more information about GMDI or MetabolicProplease contact us:info@gmdi.org
GMDIP.O. Box 1462Hillsborough, NC 27278